Masucci, Luca
 Distribuzione geografica
Continente #
NA - Nord America 5.582
EU - Europa 3.675
AS - Asia 3.585
SA - Sud America 676
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 114
OC - Oceania 20
Totale 13.839
Nazione #
US - Stati Uniti d'America 5.387
SG - Singapore 1.626
DE - Germania 907
IT - Italia 798
CN - Cina 792
BR - Brasile 530
SE - Svezia 526
VN - Vietnam 338
FR - Francia 334
PL - Polonia 258
IE - Irlanda 151
GB - Regno Unito 148
IN - India 131
HK - Hong Kong 129
FI - Finlandia 119
UA - Ucraina 114
CA - Canada 98
ID - Indonesia 97
JP - Giappone 86
BD - Bangladesh 78
RU - Federazione Russa 64
NL - Olanda 56
AR - Argentina 52
TR - Turchia 47
MX - Messico 45
AT - Austria 44
KR - Corea 39
ES - Italia 38
IQ - Iraq 33
ZA - Sudafrica 28
BE - Belgio 26
EC - Ecuador 21
SA - Arabia Saudita 21
MA - Marocco 20
AU - Australia 18
CZ - Repubblica Ceca 18
PH - Filippine 18
CH - Svizzera 16
VE - Venezuela 16
CL - Cile 14
CO - Colombia 14
LT - Lituania 14
PK - Pakistan 14
IR - Iran 13
IL - Israele 11
JO - Giordania 11
NP - Nepal 11
JM - Giamaica 10
NG - Nigeria 10
TW - Taiwan 10
AZ - Azerbaigian 9
MY - Malesia 9
TH - Thailandia 9
TN - Tunisia 9
BO - Bolivia 8
EG - Egitto 8
PE - Perù 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
CY - Cipro 7
GR - Grecia 7
CI - Costa d'Avorio 6
CR - Costa Rica 6
DO - Repubblica Dominicana 6
DZ - Algeria 6
HN - Honduras 6
KE - Kenya 6
BY - Bielorussia 5
HR - Croazia 5
HU - Ungheria 5
KZ - Kazakistan 5
PY - Paraguay 5
UY - Uruguay 5
BB - Barbados 4
GH - Ghana 4
LB - Libano 4
NO - Norvegia 4
PA - Panama 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
GT - Guatemala 3
KG - Kirghizistan 3
MD - Moldavia 3
NI - Nicaragua 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AO - Angola 2
BG - Bulgaria 2
BS - Bahamas 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
ET - Etiopia 2
GE - Georgia 2
GY - Guiana 2
LV - Lettonia 2
MM - Myanmar 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
Totale 13.628
Città #
Singapore 902
Ashburn 583
San Jose 497
Chandler 442
Warsaw 240
Beijing 165
Rome 156
Dublin 149
New York 134
Los Angeles 121
Hong Kong 118
Ann Arbor 116
Ho Chi Minh City 106
Milan 95
Hanoi 86
Jakarta 85
Lauterbourg 85
Fairfield 83
Hefei 83
Jacksonville 83
Chicago 80
Tokyo 80
Wilmington 70
Woodbridge 70
Boston 65
The Dalles 65
Council Bluffs 63
Frankfurt am Main 62
San Mateo 61
Munich 58
Houston 57
Dearborn 54
Marseille 54
Dallas 52
São Paulo 48
Nanjing 47
St Louis 47
Helsinki 44
Princeton 43
Cattolica 41
Santa Clara 41
Moscow 40
Atlanta 39
Boardman 38
Seattle 38
Seoul 37
Redwood City 30
Turku 30
Buffalo 29
London 28
Stockholm 27
Nuremberg 26
San Francisco 26
Izmir 25
Pune 25
Denver 24
Orem 24
Kent 23
Montreal 22
Nürnberg 22
Vienna 22
Brooklyn 21
Hangzhou 21
Johannesburg 21
Lawrence 21
Paris 21
Phoenix 21
Brussels 20
Cambridge 20
Lappeenranta 20
Zhengzhou 19
Da Nang 18
North Bergen 18
Redmond 18
Augusta 17
Baghdad 17
Falkenstein 17
Poplar 17
Toronto 17
Washington 17
Düsseldorf 16
Nanchang 16
Tianjin 16
Dhaka 15
Florence 15
Mexico City 15
Rio de Janeiro 15
Shanghai 14
Falls Church 13
Kunming 13
Philadelphia 13
Guangzhou 12
Hyderabad 12
Melbourne 12
Zurich 12
Amman 11
Charlotte 11
Hebei 11
Manchester 11
Mountain View 11
Totale 6.731
Nome #
Consorzio di probiotici / Probiotic mixture 549
Intestinal parasites isolated in a large teaching hospital, Italy, 1 May 2006 to 31 December 2008 493
Polymerase chain reaction-reverse cross-blot hybridization assay in the diagnosis of sporotrichoid Mycobacterium marinum infection 342
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 324
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 293
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 290
Whole-genome sequencing reveals host factors underlying critical COVID-19 266
The role of diet on gut microbiota composition 219
Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank 217
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 211
International consensus statement on microbiome testing in clinical practice 204
Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study 188
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 185
The effect of different antibiotic regimens on bacterial resistance: a systematic review 183
Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases 179
Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss 176
Entamoeba dispar: A Rare Case of Enteritis in a Patient Living in a Nonendemic Area 176
Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice 173
Effective use of nitrocellulose-blotted antigens for phage display monoclonal antibody selection. 171
In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm 170
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 167
An explainable model of host genetic interactions linked to COVID-19 severity 166
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a three-year, single-centre cohort study 165
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 164
Intestinal Parasitic Infections in Internationally Adopted Children: A 10-Year Retrospective Study 162
Clostridioides difficile Infection in Children: A 5-Year Multicenter Retrospective Study 161
European consensus conference on faecal microbiota transplantation in clinical practice 160
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 160
In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates. 157
Effects of proton pump inhibitors on the gastric mucosa-associated microbiota in dyspeptic patients 154
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 153
Faecal transplantation for Clostridium difficile infection. Three cases treated in Italy 151
A literature review of metagenomics and culturomics of the peri-implant microbiome: Current evidence and future perspectives 150
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 148
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: a pre-post analysis in a Third Level Referral Center 147
Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates 145
A patient with acute myeloid leukemia and a solid mass in the colon. 145
Multiple malaria infection in a pregnant woman from Nigeria: detection by multiplex PCR 142
Impact evaluation of a Critical Pathway for patients with Clostridium difficile infection: A pre-post analysis in a Third Level Referral Center 142
Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases 140
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues 137
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 135
Clostridium difficile: trend in an Italian Tertiary Care Hospital during fifteen years, 2002-2016 133
Reply to Seligman 132
Liver Injury, Endotoxemia, and Their Relationship to Intestinal Microbiota Composition in Alcohol-Preferring Rats 132
Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection 131
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 130
Culture-guided treatment approach for Helicobacter pylori infection: review of the literature 130
Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases 130
Serial Fecal Microbiota Infusions via Colonoscopy for Active Ulcerative Colitis: A Feasibility, Safety, and Translational Monocentric Italian Study 129
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 124
Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment 120
C9orf72 intermediate repeats confer genetic risk for severe covid-19 pneumonia independently of age 118
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 118
Conjonctival papilloma and human papillomavirus: identification of HPV types by PCR. 117
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 117
Fecal microbiota transplantation: What’s new? 116
Mapping the human genetic architecture of COVID-19 115
Genetic mechanisms of critical illness in COVID-19 115
How the gut parasitome affects human health 112
Characterizing peri-implant and sub-gingival microbiota through culturomics. First isolation of some species in the oral cavity. A pilot study 112
Nonlinear machine learning pattern recognition and bacteria-metabolite multilayer network analysis of perturbed gastric microbiome 110
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 110
SARS-CoV-2 vaccines and donor recruitment for FMT 109
Fecal microbiota transplantation for recurrent C. difficile infection in patients with inflammatory bowel disease: experience of a large-volume European FMT center 109
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 106
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 106
Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma 105
Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies 104
Laboratory handling practice for faecal microbiota transplantation 104
Validation of Two Commercial Multiplex Real-Time PCR Assays for Detection of SARS-CoV-2 in Stool Donors for Fecal Microbiota Transplantation 102
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 101
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection—single versus multiple infusions 99
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity 96
Ultra-rare RTEL1 gene variants associate with acute severity of COVID-19 and evolution to pulmonary fibrosis as a specific long COVID disorder 95
Fecal microbiota transplantation for the treatment of steroid-refractory, intestinal, graft-versus-host disease in a pediatric patient 94
Pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes 93
Laboratory handling practice for faecal microbiota transplantation 93
Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis 88
Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic 88
The Italian national faecal microbiota transplantation program: A coordinated effort against Clostridioides difficile infection 87
Actoxumab + bezlotoxumab combination: what promise for Clostridium difficile treatment? 84
comparison of the mycobacteria growth indicator tube with radiometric and solid culture for isolation of mycobacteria from clinical specimens and susceptibility testing of Mycobacterium tuberculosis 82
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone 81
PCR-reverse cross blot hybridization assay as an useful diagnostic tool in a case of Mycobacterium marinum sporotrichoid infection 77
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study 72
Protective role of a tmprss2 variant on severe covid-19 outcome in young males and elderly women 71
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions 71
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 71
Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel 71
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. 68
Culturomic and quantitative real-time-polymerase chain reaction analyses for early contamination of abutments with different surfaces: A randomized clinical trial 64
Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel 58
Clinical and molecular characterization of COVID-19 hospitalized patients 57
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males 53
Guidance for Fecal Microbiota Transplantation Trials in Ulcerative Colitis: The Second ROME Consensus Conference 49
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study 44
Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial 34
Informed Therapeutic Microbiome Modulation for Post-Infectious Irritable Bowel Syndrome: Pilot Experience of a Microbiome Clinic 26
The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males 12
Totale 13.835
Categoria #
all - tutte 57.939
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.939


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022515 0 0 18 29 35 27 10 68 34 34 155 105
2022/20231.475 195 176 90 155 104 165 89 127 194 95 53 32
2023/2024943 59 225 39 66 44 146 77 25 19 50 93 100
2024/20251.977 39 70 135 110 156 72 97 79 260 228 402 329
2025/20265.565 710 151 306 593 908 620 896 224 341 404 244 168
2026/20271.214 287 883 44 0 0 0 0 0 0 0 0 0
Totale 13.839